Literature DB >> 34724150

Opioid receptors signaling network.

Lathika Gopalakrishnan1,2,3, Oishi Chatterjee1,3,4, Namitha Ravishankar1, Sneha Suresh1, Rajesh Raju5, Anita Mahadevan6,7, T S Keshava Prasad8.   

Abstract

Opioid receptors belong to the class A G-protein-coupled receptors and are activated by alkaloid opiates such as morphine, and endogenous ligands such as endorphins and enkephalins. Opioid receptors are widely distributed in the human body and are involved in numerous physiological processes through three major classical opioid receptor subtypes; the mu, delta and kappa along with a lesser characterized subtype, opioid receptor-like (ORL1). Opioids are the most potent analgesics and have been extensively used as a therapeutic drug for the treatment of pain and related disorders. Chronic administration of clinically used opioids is associated with adverse effects such as drug tolerance, addiction and constipation. Several investigations attempted to identify the molecular signaling networks associated with endogenous as well as synthetic opiates, however, there is a paucity of a cumulative depiction of these signaling events. Here, we report a systemic collection of downstream molecules pertaining to four subtypes of opioid receptors (MOR, KOR, DOR and ORL1) in the form of a signaling pathway map. We manually curated reactions induced by the activation of opioid receptors from the literature into five categories- molecular association, activation/inhibition, catalysis, transport, and gene regulation. This led to a dataset of 180 molecules, which is collectively represented in the opioid receptor signaling network following NetPath criteria. We believe that the public availability of an opioid receptor signaling pathway map can accelerate biomedical research in this area because of its high therapeutic significance. The opioid receptors signaling pathway map is uploaded to a freely available web resource, WikiPathways enabling ease of access ( https://www.wikipathways.org/index.php/Pathway:WP5093 ).
© 2021. The International CCN Society.

Entities:  

Keywords:  NetPath; Nociception; Opioid signaling; Opioid tolerance; Post-translational modifications; Protein–protein interactions

Year:  2021        PMID: 34724150      PMCID: PMC9411393          DOI: 10.1007/s12079-021-00653-z

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.908


  75 in total

1.  A network map of IL-33 signaling pathway.

Authors:  Sneha M Pinto; Yashwanth Subbannayya; D A B Rex; Rajesh Raju; Oishi Chatterjee; Jayshree Advani; Aneesha Radhakrishnan; T S Keshava Prasad; Mohan R Wani; Akhilesh Pandey
Journal:  J Cell Commun Signal       Date:  2018-04-28       Impact factor: 5.782

2.  Differential agonist regulation of the human kappa-opioid receptor.

Authors:  A D Blake; G Bot; S Li; J C Freeman; T Reisine
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

3.  An assembly of galanin-galanin receptor signaling network.

Authors:  Lathika Gopalakrishnan; Oishi Chatterjee; Chinmayi Raj; Deepshika Pullimamidi; Jayshree Advani; Anita Mahadevan; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-11-02       Impact factor: 5.782

4.  The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.

Authors:  James D Robinson; Patricia H McDonald
Journal:  Cell Signal       Date:  2015-04-06       Impact factor: 4.315

5.  Morphine activates Arc expression in the mouse striatum and in mouse neuroblastoma Neuro2A MOR1A cells expressing mu-opioid receptors.

Authors:  Barbara Ziółkowska; Michael J Urbański; Agnieszka Wawrzczak-Bargieła; Wiktor Bilecki; Ryszard Przewłocki
Journal:  J Neurosci Res       Date:  2005-11-15       Impact factor: 4.164

Review 6.  GPCR desensitization: Acute and prolonged phases.

Authors:  Sudarshan Rajagopal; Sudha K Shenoy
Journal:  Cell Signal       Date:  2017-01-28       Impact factor: 4.315

7.  Inhibition of Gαi activity by Gβγ is mediated by PI 3-kinase-γ- and cSrc-dependent tyrosine phosphorylation of Gαi and recruitment of RGS12.

Authors:  Jiean Huang; Ancy D Nalli; Sunila Mahavadi; Divya P Kumar; Karnam S Murthy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-02-27       Impact factor: 4.052

8.  Endothelin-converting enzyme 2 differentially regulates opioid receptor activity.

Authors:  A Gupta; W Fujita; I Gomes; E Bobeck; L A Devi
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

9.  Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.

Authors:  Bronwyn Kivell; Zeljko Uzelac; Santhanalakshmi Sundaramurthy; Jeyaganesh Rajamanickam; Amy Ewald; Vladimir Chefer; Vanaja Jaligam; Elizabeth Bolan; Bridget Simonson; Balasubramaniam Annamalai; Padmanabhan Mannangatti; Thomas E Prisinzano; Ivone Gomes; Lakshmi A Devi; Lankupalle D Jayanthi; Harald H Sitte; Sammanda Ramamoorthy; Toni S Shippenberg
Journal:  Neuropharmacology       Date:  2014-08-10       Impact factor: 5.250

10.  NetPath: a public resource of curated signal transduction pathways.

Authors:  Kumaran Kandasamy; S Sujatha Mohan; Rajesh Raju; Shivakumar Keerthikumar; Ghantasala S Sameer Kumar; Abhilash K Venugopal; Deepthi Telikicherla; J Daniel Navarro; Suresh Mathivanan; Christian Pecquet; Sashi Kanth Gollapudi; Sudhir Gopal Tattikota; Shyam Mohan; Hariprasad Padhukasahasram; Yashwanth Subbannayya; Renu Goel; Harrys K C Jacob; Jun Zhong; Raja Sekhar; Vishalakshi Nanjappa; Lavanya Balakrishnan; Roopashree Subbaiah; Y L Ramachandra; B Abdul Rahiman; T S Keshava Prasad; Jian-Xin Lin; Jon C D Houtman; Stephen Desiderio; Jean-Christophe Renauld; Stefan N Constantinescu; Osamu Ohara; Toshio Hirano; Masato Kubo; Sujay Singh; Purvesh Khatri; Sorin Draghici; Gary D Bader; Chris Sander; Warren J Leonard; Akhilesh Pandey
Journal:  Genome Biol       Date:  2010-01-12       Impact factor: 13.583

View more
  3 in total

Review 1.  The placenta as a target of opioid drugs†.

Authors:  Cheryl S Rosenfeld
Journal:  Biol Reprod       Date:  2022-04-26       Impact factor: 4.161

2.  Epigenome-wide DNA methylation profiling of conditioned pain modulation in individuals with non-specific chronic low back pain.

Authors:  Burel R Goodin; Demario S Overstreet; Terence M Penn; Rahm Bakshi; Tammie L Quinn; Andrew Sims; Travis Ptacek; Pamela Jackson; D Leann Long; Edwin N Aroke
Journal:  Clin Epigenetics       Date:  2022-03-26       Impact factor: 6.551

3.  Transcriptomes of Clusterin- and S100B-transfected neuronal cells elucidate protective mechanisms against hypoxia and oxidative stress in the hooded seal (Cystophora cristata) brain.

Authors:  Gerrit A Martens; Cornelia Geßner; Carina Osterhof; Thomas Hankeln; Thorsten Burmester
Journal:  BMC Neurosci       Date:  2022-10-15       Impact factor: 3.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.